Skip to content
AlloksysAlloksys
  • Home
  • Company
    • About us
    • Leadership
    • Supervisory board
    • Scientific board
  • Cure
    • Cure and Publications
    • Major surgery
  • Community
  • Connect
Menu Close
  • Home
  • Company
    • About us
    • Leadership
    • Supervisory board
    • Scientific board
  • Cure
    • Cure and Publications
    • Major surgery
  • Community
  • Connect

News

May 2020 COVID19 RESCAP intervention obtains fast track approval

  • Post published:30/05/2020

RESCAP intervention in critically ill SARS-COV2 infected patients admitted to ICU has been approved through the Dutch Health Ministry delegated VUmc Medical Ethical Board in a fast track procedure. To…

Continue ReadingMay 2020 COVID19 RESCAP intervention obtains fast track approval

RESCAP in severe burn wound trial

  • Post published:20/01/2020

Alloksys's RESCAP platform therapeutic compound will be applied in patients that suffer from severe burn trauma. RESCAP administration is expected to significantly attenuate the overall ischemic clinical condition of these…

Continue ReadingRESCAP in severe burn wound trial

January 2020 APPIRED III

  • Post published:28/12/2018

APPIRED III study is getting well on its way with 9 centres started with including patients. These centres are Singapore NUH, CZE Eindhoven, Jessa, Hasselt, UniMed Wien Vienna, Almazov Heart…

Continue ReadingJanuary 2020 APPIRED III

Clinical Data APPIRED I and APPIRED II are basis for breakthrough

  • Post published:28/12/2018

Computational model clarifies immune response during cardiac surgery 11 October 2018 A research team led by Peter Sloot, professor of Complex Adaptive Systems at the UvA, has managed to pinpoint…

Continue ReadingClinical Data APPIRED I and APPIRED II are basis for breakthrough

Update December 2019: Solid Organ Transplantation Study well on its way

  • Post published:28/12/2018

After approval was obtained in October 2018, the kidney transplantation study with RESCAP platform technology under supervision of PI Dr Joost van der Heijden from VUmc Amsterdam found its "First…

Continue ReadingUpdate December 2019: Solid Organ Transplantation Study well on its way

Sister Company AMRIF readying up for clinical trial in chronic inflammatory disease

  • Post published:28/12/2018

AMRIF, Alloksys’s sister company is readying up for trials in several chronic inflammatory disease applications.  Among these diseases are unmet medical need applications in Neurodegenerative diseases Parkinson and Alzheimer as…

Continue ReadingSister Company AMRIF readying up for clinical trial in chronic inflammatory disease

APPIRED III started recruitment in Asia at NUHCS, Singapore

  • Post published:09/03/2018

Following the start of patient inclusion in Europe, the first Asian center participating international study APPIRED lll has started patient recruitment. The National University Heart Centre, Singapore (NUHCS) is the…

Continue ReadingAPPIRED III started recruitment in Asia at NUHCS, Singapore
  • 1
  • 2
  • Go to the next page

Contact us at info@alloksys.com or call us at +31 (0)317 466 260
Visit us at AgroBusiness Park 10, 6708 PW, Wageningen, the Netherlands